November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Hannah, a 45-year-old Brit from the future, has chronic back pain, thinning hair, sagging skin, swollen legs and red, baggy ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

California health officials are investigating a possible case of bird flu in a child who became ill after drinking raw milk, ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

Patients with dry eye associated with contact lenses had significant improvement in visual acuity and their Ocular Surface ...

The actor was diagnosed with multiple sclerosis in June 2021 and shared her illness publicly in August that year.

EU researchers are unlocking the secrets of the human eye, creating cutting-edge digital models that are transforming the ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

Andrew Kadis from Cambridge Vision Technology guides us through imaging technologies for retinal biomarkers in Alzheimer’s ...

Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop ...

In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...